Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies.: An article from: BIOTECH Patent News
Book Details
Author(s)
Gale Reference Team
Publisher
Biotech Patent News
ISBN / ASIN
B001VMKDA8
ISBN-13
978B001VMKDA1
Availability
Available for download now
Sales Rank
#99,999,999
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2008. The length of the article is 882 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies.
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: September 1, 2008
Publisher: Biotech Patent News
Volume: 22 Issue: 9
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies.
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: September 1, 2008
Publisher: Biotech Patent News
Volume: 22 Issue: 9
Distributed by Gale, a part of Cengage Learning
